Literature DB >> 11554765

Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.

Y Ariumi1, A Kaida, M Hatanaka, K Shimotohno.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat repressed the p53-dependent gene expression through its C-terminal domain of Tat (amino acid residues 73-86) independent of the involvement of NF-kappaB and coactivator CBP/p300. Although Tat did not directly bind to p53, this repression required the N-terminal domain of p53. In contrast, Tat and p53 cooperated in the activation of HIV-1 gene expression. Thus, the cross-talk between Tat and p53 may be linked with cellular transformation by HIV-1 infection or activation of HIV-1 replication. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554765     DOI: 10.1006/bbrc.2001.5626

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Knitting and untying the protein network: modulation of protein ensembles as a therapeutic strategy.

Authors:  Susana Gordo; Ernest Giralt
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

2.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

3.  p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

Authors:  Shohreh Amini; Giuseppe Mameli; Luis Del Valle; Anna Skowronska; Krzysztof Reiss; Benjamin B Gelman; Martyn K White; Kamel Khalili; Bassel E Sawaya
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  HIV infection upregulates caveolin 1 expression to restrict virus production.

Authors:  Shanshan Lin; Xiao Mei Wang; Peter E Nadeau; Ayalew Mergia
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 5.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

6.  Discovering regulated networks during HIV-1 latency and reactivation.

Authors:  Sourav Bandyopadhyay; Ryan Kelley; Trey Ideker
Journal:  Pac Symp Biocomput       Date:  2006

7.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

9.  DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.

Authors:  Yasuo Ariumi; Misao Kuroki; Ken-ichi Abe; Hiromichi Dansako; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function.

Authors:  Yasuo Ariumi; Didier Trono
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.